Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,632 | -130,403 | -96,427 | -61,544 | -29,260 |
| Depreciation Amortization | 535 | 1,153 | 1,700 | 1,109 | 547 |
| Accounts payable and accrued liabilities | -554 | -355 | -122 | -1,892 | 1,118 |
| Other Working Capital | -1,154 | -858 | 429 | -1,362 | -2,234 |
| Other Operating Activity | 8,152 | 22,237 | 15,035 | 11,079 | 2,613 |
| Operating Cash Flow | $-32,653 | $-108,226 | $-79,385 | $-52,609 | $-27,216 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -214 | -308 | -308 | -49 | -30 |
| Investing Cash Flow | $-214 | $-308 | $-308 | $-49 | $-30 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,191 | 11,838 | 10,523 | 10,085 | 8,029 |
| Other Financing Activity | -89 | -708 | -84 | -84 | 0 |
| Financing Cash Flow | $31,102 | $11,130 | $10,439 | $10,001 | $8,029 |
| Beginning Cash Position | 86,473 | 183,877 | 183,876 | 183,876 | 183,876 |
| End Cash Position | 84,708 | 86,473 | 114,623 | 141,219 | 164,660 |
| Net Cash Flow | $-1,765 | $-97,404 | $-69,254 | $-42,657 | $-19,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,653 | -108,226 | -79,385 | -52,609 | -27,216 |
| Capital Expenditure | -214 | -308 | -308 | -49 | -30 |
| Free Cash Flow | -32,867 | -108,534 | -79,693 | -52,658 | -27,246 |